1. Packhaeuser CB, Schnieders J, Oster CG, Kissel T (2004) In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 58:445–455
2. Chitkara D, Shikanov A, Kumar N, Domb AJ (2006) Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci 6:977–990
3. Heller J (2009) Patient-friendly bioerodible drug delivery systems. J Control Release 133:88–89
4. Sanofi-Aventis U.S. (2009) ELIGARD® 7.5 mg, 22.5 mg, 30 mg, 45 mg Prescribing Information (leuprolide acetate for injectable suspension).
http://products.sanofi-aventis.us/eligard/eligard_30.html
. Accessed Apr 2010
5. Dunn R, Hardee G, Polson A, Bennett A, Martin S, Wardley R, Moseley W, Krinick N, Foster T, Frank K, Cox S (1995) In-situ forming biodegradable implants for controlled release veterinary applications. Proc Int Symp Control Rel Bioact Mater 22:91–92